Luxembourg hosts international flagship cancer epidemiology conference
12 May 2021
Bringing together about 150 international scientists, clinicians, healthcare professionals and policymakers from 17 nations, the 45th edition of the Group of Cancer Epidemiology and Registration in Latin Language Countries (GRELL) conference takes place in Luxembourg in a fully virtual format.
Organised in Luxembourg for the first time by the National Cancer Registry of Luxembourg (RNC) at the Luxembourg Institute of Health (LIH), the meeting features several prominent speakers, providing an opportunity to discuss the latest developments in the field of
cancer epidemiology with a particular focus on COVID-19 and cancer, as well as childhood and adolescent cancers.
National and international prominent speakers in Luxembourg
The three-day event gathers prominent speakers, who are addressing some of the key clinical challenges related to cancer.
Some of the national and international speakers and moderators include:
- Dr Carole Bauer, Fondation Cancer Luxembourg
- Prof Gilbert Massard, University of Luxembourg
- Dr Sophie Couffignal, Head of the LIH Public Health Expertise unit and Operational Director of the Luxembourg National Cancer Registry
- Dr Guy Berchem, Associated Medical Director at LIH and President of the National Cancer Institute of Luxembourg
- Dr Claudine Backes, Epidemiologist for the Luxembourg National Cancer Registry at LIH
- Prof Michel Mittelbronn from the Laboratoire National de Santé (LNS)
- Anne Goeres, Director of the Fondatioun Kriibskrank Kanner
- Dr Eva Steliarova-Foucher, International Agency for Research on Cancer, France
- Prof Kathy Pritchard-Jones, International Society of Paediatric Oncology & University College London, UK
The association aims to coordinate the activities of the “Group for Epidemiology and Cancer Registry in Latin Laguage Coutries” (GRELL), gathered since 1976.
GRELL promotes epidemiological cancer research, mainly through the registration of cases in geographically defined populations.
Visit Luxembourg Institute of Health to know more.
Unlocking breakthroughs: Japan-Luxembourg collaboration unveils key discoveries for diagnosing neurodegenerative diseasesAn international team consisting of researchers from Japan and Luxembourg show for the first time that pathological forms of the…
Prof. Tkatchenko receives an ERC grant for drug development with AIThe physicist Prof. Alexandre Tkatchenko of the University of Luxembourg, has received a “Proof of Concept” Grant from the European…
SciLux podcast – Sophie Pilleron, cancer epidemiologistDr Sophie Pilleron is a cancer epidemiologist at the Luxembourg Institute of Health (LIH), head of the interdisciplinary ACADI team,…
10 selected Research Luxembourg results – March 2023Aelyn Chong Castro, Flickr, Pixabay, Craiyon AI Luxembourg students send five ‘mini brains’ to the ISS Luxembourg Centre for Systems…
SciLux podcast – Stefano Pozzi Mucelli, European RDI support & Alberto Noronha, CEO of NIUMFormer PhD student and research associate at the University of Luxembourg, Alberto Noronha is the co-funder and CEO of NIUM…
Research Luxembourg COVID-19 Task Force awarded the 2022 Science for Society PrizeThe 2022 Science for Society Prize, an initiative of the Science for Society Foundation, under the aegis of Fondation de…
SciLux podcast – Markus Ollert, Infection & Immunity Department directorProfessor Markus Ollert is the Director of the Infection and Immunity Department of the Luxembourg Institute of Health (LIH). He…
Shifts in human gut microbiome due to COVID-19COVID-19, caused by an infection with the SARS-CoV-2 virus, was declared a global pandemic by the World Health Organisation (WHO)…